The zero mark-up and two-vote system for drugs has made the hospital’s supporting SPD “just-in-demand”.
It is learned that Anhui Sinopharm Medical Technology Co., Ltd. (hereinafter referred to as: National Medical Technology) has completed 55 million yuan A round of financing, the investor is Jifu Venture Capital Co., Ltd.
GuoYi Technology was founded in 2014. It is a medical data and network medical service provider. Its series of products include: network hospital platform, medical data aggregation platform, smart diagnosis and treatment touch screen system, smart diagnosis and treatment mobile system, clinical intelligent lectures. Wait. According to Ding Zhenhu, the general manager of National Medical Science and Technology, the goal of National Medical Science and Technology is “to make it easy to manage medical supplies”, so it focuses on providing medical material management construction and operation solutions.
In recent years, in the field of medical supplies management, policy dividends have come one after another:
-
1) The new version of the GSP’s requirements for informatization of pharmaceutical companies makes many pharmaceutical companies urgently need to find relevant suppliers in the market to obtain corresponding support; < / li>
-
2) With the implementation and popularization of the “two-vote system”, the original sales and logistics model of multi-level distribution has been changed, and pharmaceutical distribution companies are seeking changes in the sales process or through self-built logistics. Or use third-party logistics to reach the terminal market;
-
3) With the compulsory requirement of “zero markup” for hospitals by the medical reform, it is forcing hospitals to improve the level of informatization, improve the supply chain efficiency and control, and there will be “zero inventory” and “post-consumption settlement”. “Demand.
In short, the hospital’s material management department was converted from the original profit center to the cost department. The hospital’s medical product revenue has greatly reduced. There is an urgent need to reduce costs and increase efficiency. The supporting SPD information services have also become their “just-in-demand”.
SPD —— Supply / Processing / Distribution, representing supply / processing / distribution , that is, centralized and outsourced, according to the actual application unit of the terminal Provide medicines, equipment consumables, reagents, or other medical supplies to the end-use site in a timely manner, thereby reducing the amount of inventory management business and inventory turnover at the diagnosis and treatment site, and achieving unified, refined, and efficient management of medical supplies .
SPD service was first introduced from Japan as a comprehensive service provided by third parties to provide pharmaceutical consumables management to hospitals; domestic development is relatively lagging behind, there is not a high degree of refined management in hospital logistics, and it is difficult to trace the use of pharmaceutical consumables, etc. Pain points, Need to use “supplier collaboration platform + SPD + smart terminal” integrated comprehensive solutions such as China Medical Technology to effectively link production companies, distribution companies, hospital first-level libraries, clinical departments to achieve seamless docking and optimization of information It improves the efficiency of in-hospital logistics and reduces the cost of in-hospital logistics management.
As for the market prospects, according to the market inventory of about 2,000 tertiary hospitals and about 7,000 secondary hospitals, each institution will invest 1 million yuan in procurement system to calculate the SPD related business. It will be a market of nearly 10 billion yuan; considering the continuous service charges and cooperation with pharmaceutical distribution companies and equipment and consumable companies, the market size will be doubled.
The growing market has also attracted more and more players to enter, such as With big technology , Lekang Medical Zhongyi Lekang , Wan Xu Health , Handed down from the world and other companies. Among them, Wanxue’s medical insurance information system has served 100% of Shanghai Medical Insurance Pharmacy’s customers and more than 100 hospitals. The pharmaceutical supply chain platform that has been passed down to the past has also settled in nearly 100 medical institutions. From the perspective of the market, the above dividends are now Accelerated release.